Mount criticism on the unfair behavior of foreign-invested firms

Pharmaceutical industry sources say that the unfair behavior of foreign-invested pharmaceutical firms, such as scouting of able salespersons in local pharmaceutical firms and drug wholesalers, and tight money collection period, has raised much criticism from the whole pharmaceutical industry in Korea.

Market analysts say that the imprudent scouting of the domestic firms' salespersons on the ...